Zuan-Fu Lim, a cancer cell biology graduate student in Patrick Ma’s lab at the WVU Cancer Institute, has received an American Association of Immunologists Young Investigator Award for his first place oral presentation at the 21st annual meeting of the Translational Research Cancer Centers Consortium at Seven Springs, PA.
Lung cancer cells can adopt various mechanisms of resistance to precision therapy. Lim’s research focused specifically on non-small cell lung cancers (NSCLCs) characterized by chromosomal abnormalities in the ALK gene and found that precision therapy targeting the ALK gene may not be effective because molecular drug resistance can emerge in a non-genetic fashion.
Pictured: David Klinke, PhD, of the WVU Cancer Institute congratulates Zuan-Fu Lim, a cancer cell biology graduate student, for winning an American Association of Immunologists Young Investigator Award.
Hoping to speed up the move from idea to application, West Virginia University and 23 other regional institutions have come together to create a “virtual hub” that will ultimately help speed the commercialization of groundbreaking university research.
WVCTSI and the WVU Mountaineer Health Initiative are co-sponsoring a town hall meeting to highlight research taking place across the state. “Conversation and Collaboration: WVU Community-Based Researchers and Outreach Staff Making a Difference,” offers attendees the chance to learn about the range of community engaged research and outreach across the state, meet colleagues engaged in similar work, identify common issues, and ascertain better ways to support each other in the field.
WVU cancer researcher Wei Du, MD, PhD, teamed up with researchers from Cincinnati Children’s Hospital Medical Center to focus on improving outcomes and reducing side effects of traditional stem cell transplant. Their work was recently published in Leukemia, one of the top journals in hematology.